Skip to main content
. 2015 Oct;100(10):1334–1339. doi: 10.3324/haematol.2015.125864

Figure 3.

Figure 3.

Response (by International Myeloma Working Group criteria) to POM + LoDEX treatment by prior therapy. Percentages may not sum to 100% due to rounding. BORT: bortezomib; LEN: lenalidomide; LoDEX: low-dose dexamethasone; POM: pomalidomide; PR: partial response; SCT: stem cell transplant; THAL: thalidomide; Tx: treatment; VGPR: very good partial response.